10 ASX shares I would buy in 2024

Here's where I would put my money during the next 12 months.

A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A new year is almost here, so what better time to start looking at making some new additions to your investment portfolio?

But which ASX shares could be top buys in 2024? Named below are 10 that I believe could generate strong returns for investors over the next 12 months.

Underperforming giants

The first three ASX shares I would buy are fallen giants CSL Limited (ASX: CSL), ResMed Inc. (ASX: RMD), and Treasury Wine Estates Ltd (ASX: TWE). All three have underperformed in 2023 but I believe the tide could turn and a re-rating could happen next year.

In respect to CSL, Goldman Sachs believes it "is now entering a period of more capital-efficient growth." As for ResMed, I believe concerns over the rise of drugs like Ozempic have been overdone and left its shares trading at a very attractive level. Particularly given how its addressable market remains significant even after factoring in the potential long-term impact of Ozempic.

Finally, Treasury Wine's growth could be given a boost in 2024 if China removes its wine tariffs. It has also recently completed the acquisition of a high-margin luxury wine brand in the United States.

Small caps to rally?

With inflation showing signs of being tamed, many economists are now predicting interest rate cuts next year. This could be good news for the small side of the market, which has underperformed greatly during the rate hike cycle.

Because of this, I think it could be a good idea to have a little exposure to small-cap ASX shares if your risk tolerance allows for it.

Companies I would consider buying include counterdrone technology company DroneShield Ltd (ASX: DRO), online beauty retailer Adore Beauty Group Ltd (ASX: ABY), and quick service restaurant solutions company Task Group Holdings Ltd (ASX: TSK). I believe all three have strong long-term growth outlooks.

Mining sector picks

With BHP Group Ltd (ASX: BHP) and Rio Tinto Ltd (ASX: RIO) shares ending the year close to record highs, I would reluctantly look beyond these ASX mining shares in 2024.

I think South32 Ltd (ASX: S32) shares could be a good alternative. Although FY 2024 looks set to be a poor year for the diversified miner, I believe this is all priced in. And with things looking markedly better for 2025, I expect the market to start re-rating its shares next year.

In addition, I see a lot of value in IGO Ltd (ASX: IGO) shares at the current level. Although lithium prices are expected to fall further in 2024, it appears well-placed to ride out the storm due to its ultra-low costs. It could also be an attractive M&A target.

Buying quality ASX shares

My final two ASX share picks for 2024 are gaming technology company Aristocrat Leisure Limited (ASX: ALL), which manages the top offshore sportsbooks online and cloud accounting platform provider Xero Limited (ASX: XRO).

Although these two shares have smashed the market this year, I would still buy them for next year due to the high-quality nature of their businesses and their strong long-term growth potential.

Additionally, with interest rates expected to fall, this would likely be a boost to valuations in the tech sector, which bodes well for Aristocrat and Xero.

Motley Fool contributor James Mickleboro has positions in CSL, ResMed, Treasury Wine Estates, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, DroneShield, Goldman Sachs Group, ResMed, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Adore Beauty Group. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool Australia has recommended Adore Beauty Group, CSL, DroneShield, and Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A humanoid robot is pictured looking at a share price chart
Share Market News

What is happening to these ASX software shares?

The recent sell off seems driven by renewed concerns around valuations and AI-driven disruption.

Read more »

Two kids are selling big ideas from a lemonade stand on the side of the road for cheap!
Growth Shares

Experts rate this ASX share as a buy!

A leading fund manager is calling this growing business a buy.

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Growth Shares

2 ASX 200 shares that could be top buys for growth

I’m expecting these two ASX 200 shares to deliver good growth to 2030.

Read more »

A man leaps from a stack of gold coins to the next, each one higher than the last.
Growth Shares

3 quality ASX shares to buy with $10,000

Brokers see upside for these well-run businesses.

Read more »

Growth Shares

These beaten down ASX growth shares could rise 50% to 75%

These growth shares are down but not out according to analysts.

Read more »

A older man and younger man rest, exhausted but happy after a good boxing session.
Growth Shares

Why these battered ASX shares deserve a second look

These stocks might be bruised, but not down and out.

Read more »

Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.
Growth Shares

These 4 ASX 200 stocks could jump another 70% to 80% in 2026

These stocks are expected to rocket higher.

Read more »

Excited couple celebrating success while looking at smartphone.
Growth Shares

3 stellar ASX growth shares that could rise 25% to 50%

Analysts see potential for these shares to deliver big returns for investors.

Read more »